BACKGROUND: Mental disorders (MDs) are mainly treated in primary care (PC), where psychotropic drug (PSD) prescribing is highly prevalent. Prescription of PSD is associated with clinical and non-clinical factors. PURPOSE: To describe the patterns of PSD prescribing over a 12-month period and to determine the factors associated with this in a PC population. METHODS: Cross-sectional study. Data were collected on 3815 patients, via patient interview, on sociodemographics and MDs [Diagnostic and Statistical Manual of Mental Disorders (DSM-IV criteria)]. Computerized records provided data on PSD prescribing. Multilevel logistic regressions assessed the factors that influence prescribing. RESULTS: Thirty-four per cent of PC patients were prescribed PSDs >12 months, with anxiolytics being the most commonly prescribed (22%). Fifty-three per cent of patients with any MD in this 12-month period were prescribed PSDs; however, 25% of patients without any of these disorders were also prescribed these medications. Higher rates of prescribing were associated with female gender, older age, presence of MD, being a househusband/housewife, consulting about psychological problems, increasing number of consultations and higher self-perceived disability. PSDs were less likely to be prescribed to patients born outside Spain and those consulting about physical conditions. PSD prescribing was higher in patients previously married and antipsychotic prescribing was higher in patients never married. No statistically significant associations were found between PSD prescription and education. CONCLUSIONS: PSD prescribing rates are high in Catalonia and are associated with a number of clinical and non-clinical factors. A significant proportion of patients are receiving these drugs in the absence of MD. These findings need to be considered when prescribing in PC.
BACKGROUND:Mental disorders (MDs) are mainly treated in primary care (PC), where psychotropic drug (PSD) prescribing is highly prevalent. Prescription of PSD is associated with clinical and non-clinical factors. PURPOSE: To describe the patterns of PSD prescribing over a 12-month period and to determine the factors associated with this in a PC population. METHODS: Cross-sectional study. Data were collected on 3815 patients, via patient interview, on sociodemographics and MDs [Diagnostic and Statistical Manual of Mental Disorders (DSM-IV criteria)]. Computerized records provided data on PSD prescribing. Multilevel logistic regressions assessed the factors that influence prescribing. RESULTS: Thirty-four per cent of PC patients were prescribed PSDs >12 months, with anxiolytics being the most commonly prescribed (22%). Fifty-three per cent of patients with any MD in this 12-month period were prescribed PSDs; however, 25% of patients without any of these disorders were also prescribed these medications. Higher rates of prescribing were associated with female gender, older age, presence of MD, being a househusband/housewife, consulting about psychological problems, increasing number of consultations and higher self-perceived disability. PSDs were less likely to be prescribed to patients born outside Spain and those consulting about physical conditions. PSD prescribing was higher in patients previously married and antipsychotic prescribing was higher in patients never married. No statistically significant associations were found between PSD prescription and education. CONCLUSIONS: PSD prescribing rates are high in Catalonia and are associated with a number of clinical and non-clinical factors. A significant proportion of patients are receiving these drugs in the absence of MD. These findings need to be considered when prescribing in PC.
Authors: Maria Rubio-Valera; María Teresa Peñarrubia-María; Maria Iglesias-González; Martin Knapp; Paul McCrone; Marta Roig; Ramón Sabes-Figuera; Juan V Luciano; Juan M Mendive; Ana Gabriela Murrugara-Centurión; Jordi Alonso; Antoni Serrano-Blanco Journal: Eur J Health Econ Date: 2019-02-06
Authors: Maria Rubio-Valera; Imma Beneitez; María Teresa Peñarrubia-María; Juan V Luciano; Juan M Mendive; Paul McCrone; Martin Knapp; Ramon Sabés-Figuera; Katarzyna Kocyan; Javier García-Campayo; Antoni Serrano-Blanco Journal: BMC Psychiatry Date: 2015-03-31 Impact factor: 3.630
Authors: Gustave Noufou Nana; Boukaré Doulougou; Fernando Gomez; Alban Ylli; Jack Guralnik; Maria Victoria Zunzunegui Journal: BMC Geriatr Date: 2015-07-20 Impact factor: 3.921
Authors: Maria Rubio-Valera; Judith Bosmans; Ana Fernández; Maite Peñarrubia-María; Marian March; Pere Travé; Juan A Bellón; Antoni Serrano-Blanco Journal: PLoS One Date: 2013-08-12 Impact factor: 3.240
Authors: Pilar Carrasco-Garrido; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; Jesús Esteban-Hernández; Alejandro Álvaro-Meca; Ana López-de Andrés; José Luis DelBarrio-Fernández; Rodrigo Jiménez-García Journal: Int J Environ Res Public Health Date: 2016-11-24 Impact factor: 3.390
Authors: Pablo Romero-Sanchiz; Raquel Nogueira-Arjona; Antonio García-Ruiz; Juan V Luciano; Javier García Campayo; Margalida Gili; Cristina Botella; Rosa Baños; Adoración Castro; Yolanda López-Del-Hoyo; Mª Ángeles Pérez Ara; Marta Modrego-Alarcón; Fermín Mayoral Cleríes Journal: PLoS One Date: 2017-02-27 Impact factor: 3.240
Authors: Clara Maestre-Miquel; Ana López-de-Andrés; Zichen Ji; Javier de Miguel-Diez; Arturo Brocate; Sara Sanz-Rojo; Antonio López-Farre; David Carabantes-Alarcon; Rodrigo Jiménez-García; José J Zamorano-León Journal: Int J Environ Res Public Health Date: 2021-06-11 Impact factor: 3.390
Authors: Hans Wouters; Marcel L Bouvy; Erica Cg Van Geffen; Helga Gardarsdottir; Anne M Stiggelbout; Liset Van Dijk Journal: Patient Prefer Adherence Date: 2014-02-10 Impact factor: 2.711